Prophylaxis

Displaying 11 - 20 of 49

Vaccine management revolutionises storage and handling

Vaccine management revolutionises storage and handling
  TruMed Systems has announced the introduction and commercial availability of the AccuVax Vaccine Management System. The AccuVax Vaccine Management System streamlines vaccine workflow, saves nursing time, minimises vaccine waste, safeguards vaccine potency, and helps protect against medical errors.
20th September 2017

Duodenoscope with Disposable Elevator Cap released

Duodenoscope with Disposable Elevator Cap released
PENTAX Medical Europe has obtained a CE mark for its new duodenoscope with a Disposable Elevator Cap – the DEC Duodenoscope. The product provides a breakthrough solution in infection prevention with increased reprocessing operational efficiency, while ensuring reliable therapeutic performance. The new DEC Duodenoscope (as the ED34-i10T2 will be known) will be presented for the first time during the EUS-ENDO congress, in Marseille, France, 28-29th September 2017.
20th September 2017

Hospital cleaning can protect patients from resistant bacteria

Hospital cleaning can protect patients from resistant bacteria
  Hospitals should design premises and adapt their infection control routines to a society that no longer has effective antibiotics, and that is vulnerable to fast-spreading global pandemics. This is argued in a new dissertation from Lund University in Sweden.
18th September 2017


Study demonstrates effectiveness of contraception app

Study demonstrates effectiveness of contraception app
The largest prospective observational study ever performed on the effectiveness of Fertility Awareness Based (FAB) methods (also called natural family planning) has concluded that Natural Cycles, the first app to be certified as a contraception in the EU, provides an effective alternative for women who are looking for non-hormonal options, and represents a significant improvement when compared to traditional FAB methods for contraception.
14th September 2017

The first molecular test for psychiatric disorders

The first molecular test for psychiatric disorders
Current diagnosis of schizophrenia and bipolar disorder is challenging due to a complex range of symptoms. Early diagnosis is the key to vastly improved outcomes for patients. The EU funded SCHIZDX (Developing minimally invasive, tools and technologies for high throughput, low cost molecular assays for the early diagnosis of schizophrenia and other psychiatric disorders) project has developed the first molecular test for the diagnosis of schizophrenia, VeriPsych.
11th September 2017

Game development prevents cognitive decline in the elderly

Game development prevents cognitive decline in the elderly
Information technology can be a powerful tool for preserving the cognitive functions of people over 60 years of age. This proposition was the basis of Fabio Ota’s initiative, which was undertaken in a research project supported by FAPESP’s Innovative Research in Small Business (PIPE) to test the benefits of teaching game programming techniques to a group of 46 people over the age of sixty, with the aim of developing logical reasoning and preventing cognitive decline.
9th August 2017

Optimising immunisation with T cell receptors

Optimising immunisation with T cell receptors
When T cells encounter an antigen, they proliferate and produce various types of daughter cells. A team at the Technical University of Munich (TUM) has now refuted the prevailing hypothesis that this immune response is largely predetermined by the individual structure of the T cell receptor. Instead, the influence of the T cell receptor can be described only in probabilistic terms. Such mathematical models may help to improve the design of future vaccination strategies.
1st August 2017

Microneedle patch improves efficacy of seasonal flu vaccines

Microneedle patch improves efficacy of seasonal flu vaccines
A boosting skin vaccination with a biodegradable microneedle patch and protein constructed from sequences of influenza virus subtypes could improve the effectiveness of conventional influenza vaccines, according to a study led by Georgia State University. To increase the protection offered by standard influenza vaccines, Dr. Baozhong Wang’s group made a fusion protein (4M2e-tFliC) with four different sequences of M2e from four different influenza subtypes.
24th July 2017

Mosquito net thwarts mosquitoes resistant to insecticides

Mosquito net thwarts mosquitoes resistant to insecticides
BASF has received a recommendation from the World Health Organisation (WHO) for Interceptor G2, a long-lasting insecticide-treated mosquito net (LN) based on chlorfenapyr. Chlorfenapyr is a completely new insecticide class for combating mosquitoes for public health. This is the first WHO recommendation for a product based on a new insecticide class in more than 30 years.
14th July 2017

Ergonomic mouse aims to relieve users from strain

Ergonomic mouse aims to relieve users from strain
Using computer mice more than 20 hours per week is associated with carpal tunnel syndrome. Classic computer mice force users into a pronated forearm position, placing stress on the nerves of the carpal tunnel. The PenClic R2 is an unconventional mouse that aims to relieve users from such strain by putting their hands into a more neutral position. The Penclic R2 looks like a regular mouse with a pen attached to it.
11th July 2017


Prophylaxis documents


Sign up to view our publications

Sign up

Sign up to view our downloads

Sign up

SPS IPC Drives 2017
28th November 2017
Germany Nuremberg
Cyber Security - Oil, Gas, Power 2017
29th November 2017
United Kingdom London
AI Tech World
29th November 2017
United Kingdom Olymipa, London
Maker Faire 2017
1st December 2017
Italy Rome
Virtual & Augmented Reality Creative Summit 2017
5th December 2017
United Kingdom Picturehouse Central, London